We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.67B
AUM Growth
-$192M
Cap. Flow
-$208M
Cap. Flow %
-12.46%
Top 10 Hldgs %
16.23%
Holding
2,892
New
1,004
Increased
436
Reduced
473
Closed
952

Sector Composition

Rank Sector Weight
1 Financials 9.89%
2 Technology 6.14%
3 Consumer Discretionary 5.43%
4 Healthcare 4.72%
5 Industrials 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGY icon
1776
Vaalco Energy
EGY
$609M
$44K ﹤0.01%
+16,043
New +$27.6K
SMMT icon
1777
Summit Therapeutics
SMMT
$12.1B
$44K ﹤0.01%
+18,027
New +$231K
XWEL icon
1778
XWELL
XWEL
$8.36M
$44K ﹤0.01%
+126
New +$81.8K
REED
1779
DELISTED
Reeds, Inc. Common Stock
REED
$44K ﹤0.01%
+306
New +$38.6K
KLDX
1780
DELISTED
KLONDEX MINES LTD
KLDX
$44K ﹤0.01%
18,887
-39,542
-68% -$96.2K
ISEE
1781
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$43K ﹤0.01%
+15,764
New +$43.5K
BXE
1782
DELISTED
Bellatrix Exploration Ltd.
BXE
$43K ﹤0.01%
+43,174
New +$52.8K
ACHV icon
1783
Achieve Life Sciences
ACHV
$695M
$42K ﹤0.01%
+552
New +$113K
OPTT icon
1784
Ocean Power Technologies
OPTT
$55.1M
$42K ﹤0.01%
2,474
+694
+39% +$15.3K
SIFY
1785
Sify Technologies
SIFY
$1.13B
$42K ﹤0.01%
3,820
-1,144
-23% -$13.8K
SLNO
1786
DELISTED
Soleno Therapeutics
SLNO
$42K ﹤0.01%
+1,210
New +$35.5K
TGB
1787
Trekor Metals
TGB
$3.23B
$42K ﹤0.01%
39,337
+3,821
+11% +$4.52K
CHNR icon
1788
China Natural Resources
CHNR
$5.1M
$41K ﹤0.01%
+453
New +$38.4K
BGMS
1789
Bio Green Med Solution Inc
BGMS
$4.97M
-1
Closed -$105K
NGNE icon
1790
Neurogene
NGNE
$714M
$41K ﹤0.01%
+774
New +$202K
SLS icon
1791
SELLAS Life Sciences
SLS
$2.17B
$41K ﹤0.01%
240
+13
+6% +$3.56K
GSV
1792
DELISTED
Gold Standard Ventures Corp.
GSV
$41K ﹤0.01%
30,092
-7,808
-21% -$11.9K
MNKD icon
1793
MannKind Corp
MNKD
$1.23B
$40K ﹤0.01%
20,918
-34,272
-62% -$64.1K
FLNA
1794
Filana Therapeutics
FLNA
$46.9M
$40K ﹤0.01%
+19,525
New +$167K
TCRT icon
1795
Alaunos Therapeutics
TCRT
$4.81M
$40K ﹤0.01%
88
-107
-55% -$67.8K
EVOK
1796
DELISTED
Evoke Pharma
EVOK
$39K ﹤0.01%
+109
New +$40.9K
WWR icon
1797
Westwater Resources
WWR
$77.2M
$39K ﹤0.01%
1,906
+1,688
+774% +$40.7K
SDPI
1798
DELISTED
Superior Drilling Products Inc.
SDPI
$39K ﹤0.01%
20,140
+1,891
+10% +$3.73K
ATRS
1799
DELISTED
Antares Pharma, Inc.
ATRS
$39K ﹤0.01%
+15,151
New +$37.7K
SXE
1800
DELISTED
Southcross Energy Partners, L.P.
SXE
$39K ﹤0.01%
25,695
+13,446
+110% +$22K

Similar funds

Virtu Financial's Q2 2018 Portfolio in Review

As of Q2 2018, Virtu Financial held 2,892 positions worth $1.67B, down 10% from $1.86B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Virtu Financial withdrew a net $208M in Q2 2018, closing 952 positions and reducing 473 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.9% of assets, up from 4.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Virtu Financial opened a new position in Berkshire Hathaway Class B worth $86M.

  • Virtu Financial's largest Q2 2018 buy was Berkshire Hathaway Class B: 460,798 shares worth $86M.
  • Virtu Financial added most to iShares MSCI Canada ETF in Q2 2018, an estimated $13.3M increase.
  • Virtu Financial's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $205M.
  • Virtu Financial fully exited iShares US Real Estate ETF in Q2 2018, selling an estimated $20.6M.
  • Virtu Financial's ten largest holdings make up 16% of its $1.67B portfolio in Q2 2018.
  • Virtu Financial opened 1,004 new positions and closed 952 in Q2 2018.
  • Virtu Financial's portfolio value fell 10% quarter-over-quarter to $1.67B.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.